Occurrence of High Levels of Cefiderocol Resistance in Carbapenem-Resistant Escherichia coli before Its Approval in China: a Report from China CRE-Network
Qi Wang, Longyang Jin, Shijun Sun, Yuyao Yin, Ruobing Wang, Fengning Chen, Xiaojuan Wang, Yawei Zhang, Jun Hou, Yumei Zhang, Zhijie Zhang, Liuchun Luo, Zhusheng Guo, Zhenpeng Li, Xin Lin, Lei Bi, Hui Wang
Abstract
Cefiderocol, a new siderophore cephalosporin, has been approved in the United States and Europe but not in China. At present, there are almost no antimicrobial susceptibility evaluation data on cefiderocol in China.
Topics & Concepts
ChinaCephalosporinSiderophoreBiologyAntimicrobialBiotechnologyMicrobiologyGeographyGeneticsBacteriaAntibioticsArchaeologyAntibiotic Resistance in BacteriaAntibiotics Pharmacokinetics and EfficacyPharmaceutical and Antibiotic Environmental Impacts